Physician's Money Digest
 
Feedback  |  Submit an Article
Advertisement

Your Practice >>>


May 21, 2012
Daniel S. Levine
Osiris Therapeutics said it has received approval from Health Canada to market its stem cell therapy Prochymal for the treatment of acute graft-vs-host disease in children.
May 17, 2012
Laura Joszt
In honor of the upcoming ASCO conference, here are the top 10 best-selling cancer drugs based on how much in U.S. sales they brought in last year.
May 16, 2012
Laura Joszt
Health care facilities are looking more and more toward temporary doctors to fill the vacancies from full-time physician shortages. Since full-time physicians are often highly stressed, more could appreciate the flexibility that a locum tenens career offers.
May 16, 2012
John Teixeira, CPA, MST, and Kevin Bickerstaff, CPA
Buy-sell agreements are the cornerstone in the succession plan of any business; This especially holds true with physician-owned practices.
May 14, 2012
Laura Joszt
The market for Alzheimer’s drugs might be heating up soon as a number of companies are testing similar drugs to treat the disease. The expectation is that one of these drugs will have a huge payoff.
May 11, 2012
Laura Joszt
In the U.S., 4% of all retail pharmacies had suspicious or excessive Medicare billing totaling $5.6 billion.
May 10, 2012
Rebecca Coelius
One of the great promises of health technology is the ability to monitor patients’ status outside of the office.
May 10, 2012
Ed Rabinowitz
As a former investment banker it made sense for psychiatrist Sina Saidi, MD, to take a unique approach at problem solving with patients.
May 9, 2012
Laura Joszt
Two representatives are presenting a bill to do away with the flawed SGR formula, which dictates the annual cuts to Medicare reimbursement that Congress prevents on a yearly basis.
May 8, 2012
Laura Joszt
A new bill introduced in the House would make it mandatory for drug developers to publish all data, even negative results, from cancer clinical studies.
Advertisement

Do ASCO abstracts and presentations affect your investment decisions?
 Yes.
 No.


Advertisement
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
 

 
###authentication##